Status:
TERMINATED
The Timing of Prophylactic Antibiotics in Cesarean Section and the Risk of Post-operative Febrile Morbidity
Lead Sponsor:
University of Pennsylvania
Conditions:
Cesarean Section
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether the timing of prophylactic antibiotic administration for cesarean section (immediate preoperative versus intraoperative administration) impacts the ra...
Eligibility Criteria
Inclusion
- Gestational age \> 36 weeks
- Ability to understand requirements of the study
- Elective/non-emergent cesarean section selected as route of delivery by treating physicians
Exclusion
- Known fetal anomaly
- Exposure to antibiotics within 7 days of admission, including intrapartum group B streptococcal (GBS) prophylaxis
- Emergent cesarean delivery (i.e. for fetal distress, maternal distress, obstetric hemorrhage)
- Overt maternal intrapartum infection requiring antibiotics
- Prolonged rupture of membranes (\>18 hours)
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
End Date :
July 1 2006
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00133029
Start Date
July 1 2004
End Date
July 1 2006
Last Update
August 15 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104